CeGaT GmbH

𝗠𝗮𝗷𝗼𝗿 𝘂𝗽𝗱𝗮𝘁𝗲 𝗼𝗳 𝗼𝘂𝗿 𝘁𝘂𝗺𝗼𝗿 𝗱𝗶𝗮𝗴𝗻𝗼𝘀𝘁𝗶𝗰𝘀 We are excited to announce the latest updates to our CancerPrecision® panel, reflecting the newest scientific and medical findings: • expanded gene list and breakpoint enrichment for DNA-based gene fusion diagnostics • inclusion of more pharmacogenetically relevant genes: 𝘊𝘈𝘊𝘕𝘈1𝘚 and 𝘕𝘜𝘋𝘛15 • enhanced ability to detect oncogenic viruses Our RNA-level gene fusion panel, CancerFusionRx®, also received significant updates: • expanded scope of analyzed breakpoint regions for targeted detection of recurrent gene fusions • now capable of detecting expressed viral genes at the RNA level, including HPV, EBV, MCV, and CMV For more information, take a look at our news text: https://lnkd.in/gQFSRxFq #diagnostics #genetics #tumor #update #cancer #oncology

The next panel has been revised as part of our regular updates. The Diagnostic Panel for Neuromuscular Diseases is the ideal tool for diagnosing genetic diseases of the muscle as well as diseases of the nerve fibers that activate the muscle. Like all our panels, it is based on our proprietary, high-quality ExomeXtra® enrichment. It covers all protein-coding regions as well as disease-relevant intronic and intergenic variants. In addition, the ExomeXtra® enrichment enables a genome-wide CNV calling with similar performance to array CGH. Our panel thus provides the ideal basis for genetic diagnostics of neuromuscular conditions. Have a look at our website to learn more about this panel: https://lnkd.in/eCYDqFQ6 #genetics #diagnostics #update #neuromuscular

Did you know small RNA sequencing can identify biomarkers for disease diagnostics or classification, like for cancer? Small RNAs are involved in various functions, including RNA interference, gene silencing, and epigenetic modifications. By sequencing, we can determine the diverse expression of all small RNAs in a sample. Analyzing these expression profiles helps us to better understand dysregulation under pathological conditions and to identify key biomarkers in disease pathogenesis. Learn more here: https://lnkd.in/ecuYBZAe #smallRNA #sequencing #NGS

Work with us in one of the most exciting fields of life sciences: CeGaT is looking for a Content Marketing Manager (m/f/d) to join our dynamic team in Tübingen, Germany! If you would like to contribute to the advancement of genetic diagnostics and sequencing services, take a look at our open positions and apply today: https://lnkd.in/e9wytZuN #joinourteam #contentmarketing #openposition

𝗧𝗵𝗲 𝗿𝗲𝗰𝗼𝗿𝗱𝗶𝗻𝗴 𝗼𝗳 𝗼𝘂𝗿 𝘄𝗲𝗯𝗶𝗻𝗮𝗿 𝗼𝗻 𝗲𝘅𝗼𝗺𝗲 𝗱𝗶𝗮𝗴𝗻𝗼𝘀𝘁𝗶𝗰𝘀 𝗶𝘀 𝗻𝗼𝘄 𝗮𝘃𝗮𝗶𝗹𝗮𝗯𝗹𝗲: https://lnkd.in/emvZ7wE2 CeGaT ExomeXtra® offers the all-in-one solution for your patient diagnostics. Watch the webinar recording and find out what this means in clinical practice: Dr. Heinz Gabriel and Dr. Stefan Griesbach illustrate the benefits and advantages of our exome diagnostics using different examples from routine diagnostic practice. #webinar #recording #genetics #diagnostics #exome #rarediseases

Great news! We have expanded our preventive and predictive genetic diagnostics by adding tumor, kidney, and metabolic diseases, as well as Alzheimer's dementia and Parkinson's. This comprehensive update enhances our ability to provide valuable insights into an individual's genetic predisposition, supporting the adaptation of lifestyle and life choices. Read our news to find out in detail what's new: https://lnkd.in/enG-RmJs #GeneticDiagnostics #Prevention #Health #Dementia #Parkinsons

🚀 𝗖𝗲𝗚𝗮𝗧 𝗲𝗻𝗵𝗮𝗻𝗰𝗲𝘀 𝘀𝗲𝗾𝘂𝗲𝗻𝗰𝗶𝗻𝗴 𝗰𝗮𝗽𝗮𝗰𝗶𝘁𝘆 We are excited to share that we've added a second NovaSeqᵀᴹ X Plus system to our lab, expanding our sequencing capacities alongside our five NovaSeqᵀᴹ 6000s and the first NovaSeqᵀᴹ X Plus we acquired last year. This is great news against the backdrop of ever-increasing demand for our outstanding sequencing services! For more information, take a look at our news text: https://lnkd.in/eS2SpT6V #sequencing #novaseqxplus #lab #capacity #illumina

𝗖𝗮𝗻𝗰𝗲𝗿𝗗𝗲𝘁𝗲𝗰𝘁® 𝗻𝗼𝘄 𝗶𝗱𝗲𝗻𝘁𝗶𝗳𝗶𝗲𝘀 𝗳𝘂𝘀𝗶𝗼𝗻𝘀 𝗶𝗻 𝗰𝗳𝗗𝗡𝗔 As part of our regular updates, we have added a significant upgrade to our CancerDetect® panel: The liquid biopsy-based analysis now detects selected, therapy-relevant gene fusions and thus provides important information for oncological treatment planning. Learn more: https://lnkd.in/ehKSGFqS #update #tumor #diagnostics #genetics #liquidbiopsy #news

𝗧𝗵𝗲𝗿𝗲 𝗮𝗿𝗲 𝗼𝗻𝗹𝘆 𝘁𝘄𝗼 𝗱𝗮𝘆𝘀 𝗹𝗲𝗳𝘁 𝘂𝗻𝘁𝗶𝗹 𝗼𝘂𝗿 𝘄𝗲𝗯𝗶𝗻𝗮𝗿 𝗼𝗻 𝗖𝗲𝗚𝗮𝗧 𝗘𝘅𝗼𝗺𝗲𝗫𝘁𝗿𝗮®! Join us on June 20, when Dr. Stefan Griesbach and Dr. Heinz Gabriel will present our webinar, "How ExomeXtra® Solves Patient Cases: A Four-Year Retrospective." Register now and learn how ExomeXtra® can shorten your patient's diagnostic odyssey to one month: https://lnkd.in/gX3NheFY #NGS #Exome #Webinar #RareDisease #Diagnostics #FreeWebinar #JoinUs 

Meet Eric R. Miller at the CCMG-CCGM 48th Annual Scientific Meeting from June 16-19. Visit him at booth no.14 and learn more about CeGaT's genetic diagnostics portfolio. #genetics #NGS #meetus #CCMG #meeting #conference